The life science industry in Denmark has developed into one of the strongest clusters in Europe. With excellent interplay between public and private partners and a unique test environment, Denmark turns clinical research into business. For many years, Denmark has constituted an international health laboratory, attracting international businesses and researchers.

Reasons include the presence of several different types of healthcare industries, a long-standing tradition for efficient public-private partnerships, plus a keen political focus on creating framework conditions conducive to research and business development in healthcare and welfare.

Over the past five decades, the Indian life sciences sector has witnessed exponential growth both in terms of broadening of scope and deepening of capabilities across the industry value chain. One of the key challenges the sector faces is the need for a strong collaboration between life science and healthcare companies not just on products but also on solutions to help meet the demand-supply mismatch. The need of the hour is for the product-push models to be complemented with service-oriented models that place a high priority on patients’ interests.

  • The industry has steadily grown and witnessed a surge from USD 2.02 billion in 2009 to USD 3.9 billion in 2015 at a Compound Annual Growth Rate (CAGR) of 15.8%. As per industry estimates, the Indian medical devices market will grow to USD 50 billion by 2025. Currently, India is counted among the top 20 global medical devices market and is the 4th largest medical devices market in Asia after Japan, China and South Korea. Equipment and Instruments (surgical and non-surgical) form the largest segment (53% of the Indian medical device industry), constituting about USD 2.7 Billion (2017), while the estimated market size of the consumer and durable segment is USD 1404 million.